EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Biomaterial-Based Sustained-Release Drug Formulations for Localized Cancer Immunotherapy

Khizra Mujahid, Isra Rana, Ivan Hardianto Suliman, Zhen Li, Jiang Wu iD, Huacheng He iD, Jutaek Nam iD

ACS Applied Bio Materials · 19.08.2024 · 7 (8) · 4944-4961

DOI: 10.1021/acsabm.3c00808 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift ACS Applied Bio Materials, online erschienen am 05.12.2023. Verfasst von Khizra Mujahid und 6 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Chonnam National University, Gwangju 61186, South Korea. Hauptthemen laut MEDLINE: Immunotherapy, Delayed-Action Preparations, Neoplasms, Biocompatible Materials. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 195 Literaturangaben. Gefördert von: Chonnam National University, National Research Foundation of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer immunotherapy has revolutionized clinical cancer treatments by taking advantage of the immune system to selectively and effectively target and kill cancer cells. However, clinical cancer immunotherapy treatments often have limited efficacy and/or present severe adverse effects associated primarily with their systemic administration. Localized immunotherapy has emerged to overcome these limitations by directly targeting accessible tumors via local administration, reducing potential systemic drug distribution that hampers drug efficacy and safety. Sustained-release formulations can prolong drug activity at target sites, which maximizes the benefits of localized immunotherapy to increase the therapeutic window using smaller dosages than those used for systemic injection, avoiding complications of frequent dosing. The performance of sustained-release formulations for localized cancer immunotherapy has been validated preclinically using various implantable and injectable scaffold platforms. This review introduces the sustained-release formulations developed for localized cancer immunotherapy and highlights their biomaterial-based platforms for representative classes, including inorganic scaffolds, natural hydrogels, synthetic hydrogels, and microneedle patches. The design rationale and other considerations are summarized for further development of biomaterials for the construction of optimal sustained-release formulations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ImmunotherapyDelayed-Action PreparationsNeoplasmsBiocompatible MaterialsHumansAnimalsHydrogelsDrug CompoundingAntineoplastic AgentsMaterials Testing

Stichwörter der Autor:innen

hydrogelsimplantslocalized immunotherapyscaffoldssustained-release formulations

Substanzen

Delayed-Action PreparationsBiocompatible MaterialsHydrogelsAntineoplastic Agents

Autor:innen und Institutionen

  • College of Pharmacy, Chonnam National University, Gwangju 61186, South Korea.
  • School of Pharmaceutical Sciences, Key Laboratory of Biotechnology and Pharmaceutical Engineering, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China.
  • Oujiang Laboratory (Zhejiang Lab for Regenerative Medicine, Vision and Brain Health), Wenzhou, Zhejiang 325000, P. R. China.

ORCID-Profile: Jiang Wu, Huacheng He, Jutaek Nam

Förderung

  • Chonnam National University
  • National Research Foundation of Korea

Zitieren

APA

Mujahid, K., Rana, I., Suliman, I. H., Li, Z., Wu, J., He, H., & Nam, J. (2024). Biomaterial-Based Sustained-Release Drug Formulations for Localized Cancer Immunotherapy. ACS Applied Bio Materials, 7(8), 4944-4961. https://doi.org/10.1021/acsabm.3c00808

Vancouver

Mujahid K, Rana I, Suliman IH, Li Z, Wu J, He H, et al. Biomaterial-Based Sustained-Release Drug Formulations for Localized Cancer Immunotherapy. ACS Applied Bio Materials. 2024;7(8):4944-4961. doi:10.1021/acsabm.3c00808

BibTeX
@article{Mujahid2024,
  author = {Mujahid, Khizra and Rana, Isra and Suliman, Ivan Hardianto and Li, Zhen and Wu, Jiang and He, Huacheng and Nam, Jutaek},
  title = {Biomaterial-Based Sustained-Release Drug Formulations for Localized Cancer Immunotherapy},
  journal = {ACS Applied Bio Materials},
  year = {2024},
  volume = {7},
  number = {8},
  pages = {4944--4961},
  doi = {10.1021/acsabm.3c00808}
}
Kostenlos starten →